Cover Image
市場調查報告書

亞急性皮膚紅斑狼瘡(CCLE)及圓盤狀紅斑狼瘡(DLE):全球臨床實驗檢討

Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H1, 2017

出版商 GlobalData 商品編碼 318330
出版日期 內容資訊 英文 56 Pages
訂單完成後即時交付
價格
Back to Top
亞急性皮膚紅斑狼瘡(CCLE)及圓盤狀紅斑狼瘡(DLE):全球臨床實驗檢討 Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H1, 2017
出版日期: 2017年06月30日 內容資訊: 英文 56 Pages
簡介

本報告提供亞急性皮膚紅斑狼瘡(CCLE)及圓盤狀紅斑狼瘡(DLE)的臨床試驗相關的基本資料和數據,為您彙整實驗數量及受驗者的募集情況,各階段趨勢,臨床試驗的主要製藥企業及研究機關簡介等資料。

簡介

  • 亞急性皮膚紅斑狼瘡(CCLE)及圓盤狀紅斑狼瘡(DLE)
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 歐洲主要國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量

G7各國臨床實驗數量:免疫疾病治療藥臨床實驗上亞急性皮膚紅斑狼瘡(CCLE)及圓盤狀紅斑狼瘡(DLE)所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對像

贊助商類別的臨床實驗數量

有潛力的贊助商

亞急性皮膚紅斑狼瘡(CCLE)及圓盤狀紅斑狼瘡(DLE)治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Celgene Corporation
    • Astion Pharma A/S
    • Amgen Inc.
    • Rigel Pharmaceuticals, Inc.
    • Immunomedics, Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Department of Health, South Africa
    • Florida Academic Dermatology Centers
    • The Newcastle upon Tyne Hospitals NHS Foundation Trust
    • Shahid Beheshti University of Medical Sciences
    • The Cleveland Clinic
    • Wake Forest University
    • New York University School of Medicine
    • National Cancer Institute
    • University of Leipzig

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4291CTIDB

GlobalData's clinical trial report, "Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H1, 2017" provides an overview of Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) clinical trials scenario. This report provides top line data relating to the clinical trials on Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • GlobalData Clinical Trials Report Coverage 6
  • Clinical Trials by Region 7
  • Clinical Trials and Average Enrollment by Country 8
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 11
  • Top Five Countries Contributing to Clinical Trials in Europe 12
  • Top Countries Contributing to Clinical Trials in North America 13
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 14
  • Clinical Trials by G7 Countries: Proportion of Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) to Immunology Clinical Trials 15
  • Clinical Trials by Phase in G7 Countries 17
  • Clinical Trials in G7 Countries by Trial Status 18
  • Clinical Trials by E7 Countries: Proportion of Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) to Immunology Clinical Trials 19
  • Clinical Trials by Phase 21
  • In Progress Trials by Phase 22
  • Clinical Trials by Trial Status 23
  • Clinical Trials by End Point Status 25
  • Subjects Recruited Over a Period of Time 26
  • Clinical Trials by Sponsor Type 27
  • Prominent Sponsors 28
  • Top Companies Participating in Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials 30
  • Prominent Drugs 32
  • Clinical Trial Profile Snapshots 34

Appendix 54

  • Abbreviations 54
  • Definitions 54
  • Research Methodology 55
  • Secondary Research 55
  • About GlobalData 56
  • Contact Us 56
  • Source 56

List of Tables

List of Tables

  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials by Region, 2017* 7
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 11
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 14
  • Proportion of Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) to Immunology Clinical Trials, G7 Countries (%), 2017* 16
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) to Immunology Clinical Trials, E7 Countries (%), 2017* 20
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials by Phase, 2017* 21
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 22
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 31
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 33

List of Figures

List of Figures

  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
  • Proportion of Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) to Immunology Clinical Trials, G7 Countries (%), 2017* 15
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
  • Proportion of Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) to Immunology Clinical Trials, E7 Countries (%), 2017* 19
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials by Phase (%), 2017* 21
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 22
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 23
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30
  • Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32
  • GlobalData Methodology 55
Back to Top